TCL Archive NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy October 26, 1984
TCL Archive Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial April 27, 2012